First Update of the International ASAS Consensus Statement for the Use of Anti-TNF Agents in Patients With Ankylosing Spondylitis

Annals of the Rheumatic Diseases - United Kingdom
doi 10.1136/ard.2005.040758
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Recommendations for Starting Anti TNF-α in Patients With Ankylosing Spondylitis

Reumatismo
Rheumatology
2011English

Anti-TNF Therapy in Ankylosing Spondylitis: Insights for the Clinician

Therapeutic Advances in Musculoskeletal Disease
RheumatologyOrthopedicsSports Medicine
2010English

International Consensus Statement on the Use of Uterotonic Agents During Caesarean Section

Anaesthesia
AnesthesiologyPain Medicine
2019English

Anti TNF-α Therapy Might Be Responsible for an Increased Incidence of Varicocele in Patients With Ankylosing Spondylitis

Turkish Journal of Medical Sciences
Medicine
2014English

A Prospective Clinical Investigation of the Effects of Anti-TNF Alpha Therapy on Exercise Capacity in Patients With Ankylosing Spondylitis

Turkish Journal of Medical Sciences
Medicine
2019English

Anti-Tumour Necrosis Factor Therapy for Ankylosing Spondylitis: International Experience

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2002English

TNF-alpha Antagonists for Treatment of Juvenile Ankylosing Spondylitis

Pediatric Rheumatology
ImmunologyPediatricsRheumatologyAllergyPerinatologyChild Health
2011English

Response to Anti-TNF-Α Treatment for Secondary Renal Amyloidosis in a Patient With Ankylosing Spondylitis

Reumatismo
Rheumatology
2011English

P082 Circulating Mir-145 as a Marker of Therapeutic Response in Patients With Ankylosing Spondylitis Receiving Anti-TNF Therapy

2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy